BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12003779)

  • 1. Pro-EMAP II is not primarily cleaved by caspase-3 and -7.
    Zhang FR; Schwarz MA
    Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1239-44. PubMed ID: 12003779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-surface associated p43/endothelial-monocyte-activating-polypeptide-II in hepatocellular carcinoma cells induces apoptosis in T-lymphocytes.
    Faisal W; Symonds P; Panjwani S; Heng Y; Murray JC
    Asian J Surg; 2007 Jan; 30(1):13-22. PubMed ID: 17337366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.
    Murray JC; Symonds P; Ward W; Huggins M; Tiga A; Rice K; Heng YM; Todd I; Robins RA
    J Immunol; 2004 Jan; 172(1):274-81. PubMed ID: 14688335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7.
    Behrensdorf HA; van de Craen M; Knies UE; Vandenabeele P; Clauss M
    FEBS Lett; 2000 Jan; 466(1):143-7. PubMed ID: 10648830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.
    Murray JC; Heng YM; Symonds P; Rice K; Ward W; Huggins M; Todd I; Robins RA
    J Leukoc Biol; 2004 May; 75(5):772-6. PubMed ID: 14982944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of EMAP II by hypoxia.
    Matschurat S; Knies UE; Person V; Fink L; Stoelcker B; Ebenebe C; Behrensdorf HA; Schaper J; Clauss M
    Am J Pathol; 2003 Jan; 162(1):93-103. PubMed ID: 12507893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induced by a corneal-endothelium-derived cytokine.
    Liu SH; Gottsch JD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3152-9. PubMed ID: 10586937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis.
    Knies UE; Behrensdorf HA; Mitchell CA; Deutsch U; Risau W; Drexler HC; Clauss M
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12322-7. PubMed ID: 9770485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation.
    Chang SY; Park SG; Kim S; Kang CY
    J Biol Chem; 2002 Mar; 277(10):8388-94. PubMed ID: 11741979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of EMAP II in the developing and adult mouse.
    Knies UE; Kröger S; Clauss M
    Apoptosis; 2000 Apr; 5(2):141-51. PubMed ID: 11232242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo.
    Murray JC; Barnett G; Tas M; Jakobsen A; Brown J; Powe D; Clelland C
    Am J Pathol; 2000 Dec; 157(6):2045-53. PubMed ID: 11106577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.
    Xu H; Malinin NL; Awasthi N; Schwarz RE; Schwarz MA
    J Biol Chem; 2015 Apr; 290(15):9753-66. PubMed ID: 25724651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer.
    Youssef MM; Symonds P; Ellis IO; Murray JC
    Br J Cancer; 2006 Sep; 95(6):735-43. PubMed ID: 16929248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiological processes.
    van Horssen R; Eggermont AM; ten Hagen TL
    Cytokine Growth Factor Rev; 2006 Oct; 17(5):339-48. PubMed ID: 16945568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
    Berger AC; Alexander HR; Tang G; Wu PS; Hewitt SM; Turner E; Kruger E; Figg WD; Grove A; Kohn E; Stern D; Libutti SK
    Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial-monocyte-activating polypeptide II.
    Tas MP; Murray JC
    Int J Biochem Cell Biol; 1996 Aug; 28(8):837-41. PubMed ID: 8811833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of endothelial monocyte-activating polypeptide-II in acute lung inflammation.
    Journeay WS; Janardhan KS; Singh B
    Inflamm Res; 2007 May; 56(5):175-81. PubMed ID: 17393072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EMAPII cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPII component.
    Shalak V; Kaminska M; Mitnacht-Kraus R; Vandenabeele P; Clauss M; Mirande M
    J Biol Chem; 2001 Jun; 276(26):23769-76. PubMed ID: 11306575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial-monocyte-activating polypeptide II induces rat C6 glioma cell apoptosis via the mitochondrial pathway.
    Liu LB; Xie H; Xue YX; Liu YH; Li Z; Wang P
    Biochem Biophys Res Commun; 2015 Feb; 457(4):595-601. PubMed ID: 25600803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
    Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
    Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.